These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29886724)

  • 1. Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline Depression.
    Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S; Kim MS; Lee JS;
    J Stroke; 2018 May; 20(2):258-267. PubMed ID: 29886724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive Symptoms in Stroke Patients: Are There Sex Differences?
    Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S
    Cerebrovasc Dis; 2020; 49(1):19-25. PubMed ID: 32023608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Stroke Depressive Symptoms: Varying Responses to Escitalopram by Individual Symptoms and Lesion Location.
    Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S; Kim MS; Lee JS
    J Geriatr Psychiatry Neurol; 2021 Nov; 34(6):565-573. PubMed ID: 32912058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Changes in Post-Stroke Depression, Emotional Incontinence, and Anger.
    Kwon B; Lee EJ; Park S; Lee JS; Lee MH; Jeong D; Lee D; Kwon HS; Chang DI; Park JH; Cha JK; Heo JH; Sohn SI; Kim DE; Choi-Kwon S; Kim JS
    J Stroke; 2021 May; 23(2):263-272. PubMed ID: 34102761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study on the prevalence and risk factors of poststroke depression.
    De Ryck A; Brouns R; Fransen E; Geurden M; Van Gestel G; Wilssens I; De Ceulaer L; Mariën P; De Deyn PP; Engelborghs S
    Cerebrovasc Dis Extra; 2013 Jan; 3(1):1-13. PubMed ID: 23626594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
    Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.
    Gorman JM; Korotzer A; Su G
    CNS Spectr; 2002 Apr; 7(4 Suppl 1):40-4. PubMed ID: 15131492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
    Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.
    Angermann CE; Gelbrich G; Störk S; Gunold H; Edelmann F; Wachter R; Schunkert H; Graf T; Kindermann I; Haass M; Blankenberg S; Pankuweit S; Prettin C; Gottwik M; Böhm M; Faller H; Deckert J; Ertl G;
    JAMA; 2016 Jun; 315(24):2683-93. PubMed ID: 27367876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.
    Diez-Quevedo C; Masnou H; Planas R; Castellví P; Giménez D; Morillas RM; Martín-Santos R; Navinés R; Solà R; Giner P; Ardèvol M; Costa J; Diago M; Pretel J
    J Clin Psychiatry; 2011 Apr; 72(4):522-8. PubMed ID: 21034680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
    Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M
    Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Post-Stroke Depression.
    Starkstein SE; Hayhow BD
    Curr Treat Options Neurol; 2019 Jun; 21(7):31. PubMed ID: 31236751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study.
    De Ryck A; Fransen E; Brouns R; Geurden M; Peij D; Mariën P; De Deyn PP; Engelborghs S
    J Neurol Sci; 2014 Dec; 347(1-2):159-66. PubMed ID: 25451004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hyperbaric oxygen on post-stroke depression.
    Guo H; Ge YR; Dong YB; Zhao XC; Su GL; Wang JC
    World J Psychiatry; 2023 May; 13(5):226-233. PubMed ID: 37303936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with post-stroke depression and emotional incontinence: lesion location and coping styles.
    Wei C; Gao J; Chen L; Zhang F; Ma X; Zhang N; Zhang W; Xue R; Luo L; Hao J
    Int J Neurosci; 2016; 126(7):623-9. PubMed ID: 26005045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of escitalopram on sleep problems in depressed patients.
    Lader M; Andersen HF; Baekdal T
    Hum Psychopharmacol; 2005 Jul; 20(5):349-54. PubMed ID: 15912558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Associations between Fatigue, Depression, and Apathy after Stroke: Results of the Cognition and Affect after Stroke, a Prospective Evaluation of Risks Study.
    Douven E; Köhler S; Schievink SHJ; van Oostenbrugge RJ; Staals J; Verhey FRJ; Aalten P
    Cerebrovasc Dis; 2017; 44(5-6):330-337. PubMed ID: 29073590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
    Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
    Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.